Market Movers: Microstrategy, Coinbase, and Intuitive Surgical Lead Surge

1. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated surged by 14.36%. Maxim Group initiated coverage on Microstrategy with a Buy rating and a price target of $1835.00. Canaccord Genuity maintained their Buy rating, lowering the price target to $1826.00. TD Cowen maintained their Buy rating, raising the price target to $1880.00.

2. Coinbase Global (Nasdaq: COIN)
Coinbase Global surged by 10.53%. Coinbase Global reported Q1 2024 revenue of $1.638 billion as of March 31, 2024. Needham reiterated a Buy rating with an updated price target of $260.00, while Barclays maintained an Underweight rating with a target of $196.00. Multiple insider transactions were disclosed.

3. Intuitive Surgical (Nasdaq: ISRG)
Intuitive Surgical surged by 9.34%. Intuitive Surgical's Q1 2024 revenue was $1.891 billion, up 11.46% year-over-year. Truist Securities, Morgan Stanley, Evercore ISI Group, and Baird maintained their ratings with target prices of $520, $475, $410, and $503, respectively. Barclays maintains overweight with a $490 target.

4. Starbucks (Nasdaq: SBUX)
Starbucks surged by 6.85%. Starbucks saw a notable increase in transaction volume influenced by Elliot Management's acquisition of significant shares. Wedbush and TD Cowen both maintained their neutral and hold ratings respectively. Also, Starbucks' online ordering faced disruptions due to a Microsoft outage. Additionally, Starbucks and Mercedes-Benz announced a partnership to install EV chargers at over 100 U.S. locations.

5. Doordash (NYSE: DASH)
Doordash gained solidly by 5.8%. Doordash's 2024 Q1 reported revenue of $25.13 billion. On July 17, Doordash disclosed four insider trading transactions, and on July 15, six insider trading transactions with major shareholder Tony Xu purchasing 54,200 shares. JMP Securities and Wolfe Research rated Doordash as outperform, with target prices of $140 and $130, respectively.